Cytokinetics | CYTK - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Amgen USD 95.64B 94.98B 2026-06
Arca Biopharma USD 4.6M 4.1M 2026-03
Bayer EUR 675M 87M 2025-12
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 407M 4M 2026-06
Capricor Therapeutics 3.05M 2.46M 2025-12
Cytokinetics USD 34.83M 1.5M 2026-06
Eisai JPY 1.96B 409M 2026-06
Eli Lilly USD 114.7M 134.3M 2025-09
Exelixis USD 23.4M 3.9M 2023-09
Geron USD 7.15M 150K 2026-03
Halozyme Therapeutics USD 5.59M 80K 2026-06
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Ligand Pharmaceuticals USD 1.78M 875K 2025-12
Merck USD 525M 46M 2026-06
Novartis USD 462M 119M 2026-06
Pfizer USD 667M 4M 2026-06
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06